The Northern Health Science Alliance (NHSA) in the UK has signed a memorandum of understanding (MoU) with Singapore-based firm Zicom MedTacc to boost the growth of the medtech sector in Northern England.

Under the terms of the strategic partnership, Singaporean medtech companies will come to Northern England for the development and internationalisation of new medical technology.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

These companies will be able to carry out British clinical validation and evaluate economic impact through the NHSA, while the Northern region will have access to new technologies and treatments.

NHSA CEO Dr Hakim Yadi said: “We have been working with Zicom MedTacc for the last two years.

“This MoU formalises our existing working relationship and will support us in establishing a more enduring partnership.

“This offers practical commercial opportunities for both medtech companies and life science researchers in Singapore, as well as in the North of England.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
“This offers practical commercial opportunities for both medtech companies and life science researchers in Singapore, as well as in the North of England.”

“We hope it encourages collaboration between the two countries, which will enable companies from both geographies to expand into their reciprocal international markets.”

Yadi further added that the deal will aid Northern medtech diagnostic and digital health companies to launch their products in Asia Pacific countries through NHSA’s strategic partners in Singapore.

Through the deal, NHSA also intends to support high-skilled jobs and investment in the region over long-term.

Zicom MedTacc chief executive Kok Hwee said: “We have forged a close partnership with the NHSA and are confident that through the NHSA, we would be able to help more Singaporean healthcare and medical technology companies which are interested in establishing a presence in the North of England.

“Likewise, we are extremely delighted to be able to provide support to UK companies coming to Singapore to explore opportunities, be it research and clinical collaborations or as a launchpad for breaking into the Singapore or other Asian markets.”